Citations

Clear

3314 citation(s) found for "Do, Alexander".

Surgical Excision of a Thrombosed Persistent Median Artery Causing Carpal Tunnel–Like Symptoms
Bartels, D , Shin, Alexander Y. , Bartels, Douglas W , Shin, Alexander Y

Mayo Clinic

JBJS Case Connector | August 12, 2020 | Volume: 10 | Issue: 3 | Pages: e20.00139-e20.00139

10.2106/jbjs.cc.20.00139 | PMID 32910613 Get It

Case: A 51-year-old man presented with pain and paresthesias in the median nerve distribution and a subjective loss of grip strength. Imaging revealed a thrombosed persistent median artery in the carpal tunnel abutting the median nerve. The thrombosed portion of the artery was surgically excised, and the patient experienced resolution of symptoms. Conclusion: Persistent median artery thrombosis is rare and can cause carpal tunnel syndrome. Ultrasound is a useful tool for diagnosis and appropriate surgical planning. Although treatment with systemic anticoagulation is an option, surgical excision resulted in resolution of symptoms and an excellent short-term outcome.
Comparing the Efficacy of Syngeneic Iliac and Femoral Allografts with Iliac Crest Autograft in a Rat Model of Lumbar Spinal Fusion
Elder, Benjamin D. , Perdomo‐Pantoja, Alexander , Locke, John , Cottrill, Ethan , Lo, Sheng-Fu Larry , Holmes, Christina , Ishida, Wataru , Witham, Timothy F.

Mayo Clinic

No container title available | August 10, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-27369/v2 Get It

Abstract Background: Despite widespread use of femoral-sourced allografts in clinical spinal fusion procedures and the increasing interest in using femoral reamer–irrigator–aspirator (RIA) autograft in clinical bone grafting, few studies have examined the efficacy of femoral grafts compared to iliac crest grafts in spinal fusion. The objective of this study was to directly compare the use of autologous iliac crest with syngeneic femoral and iliac allograft bone in the rat model of lumbar spinal fusion.Methods: Single-level bilateral posterolateral intertransverse process lumbar spinal fusion surgery was performed on Lewis rats divided into three experimental groups: iliac crest autograft; syngeneic iliac crest allograft; and syngeneic femoral allograft bone. Eight weeks postoperatively, fusion was evaluated via microCT analysis, manual palpation and histology. In vitro analysis of the colony-forming and osteogenic capacity of bone marrow cells derived from rat femurs and hips was also performed to determine whether there was a correlation with the fusion efficacy of these graft sources.Results: Although no differences were observed between groups in CT fusion mass volumes, iliac allografts displayed an increased number of radiographically fused fusion masses and a higher rate of bilateral fusion via manual palpation. Histologically, hip-derived grafts showed better integration with host bone than femur derived ones, likely associated with the higher concentration of osteogenic progenitor cells observed in hip-derived bone marrow. Conclusions: This study demonstrates the feasibility of using syngeneic allograft bone in place of autograft bone within inbred rat fusion models and highlights the need for further study of femoral-derived grafts in fusion.
β3 integrin immunohistochemistry as a method to predict sentinel lymph node status in patients with primary cutaneous melanoma
Quattrocchi, Enrica , Sominidi‐Damodaran, Sindhuja , Murphree, Dennis H. , Meves, Alexander

Mayo Clinic

International Journal of Dermatology | August 9, 2020 | Volume: 59 | Issue: 10 | Pages: 1241-1248

10.1111/ijd.15125 | PMID 32772371 Get It

AbstractBackgroundIntegrins are heterodimeric proteins composed of noncovalently linked ɑ and β subunits which are essential for a wide range of normal physiology and also play prominent roles in cancer. Here we tested whether integrin expression in diagnostic skin biopsies is associated with sentinel lymph node (SLN) metastasis.MethodsWe utilized a cohort of 854 consecutive patients with primary cutaneous melanoma to quantify the expression of β integrin subunits by reverse transcriptase quantitative PCR (RT‐qPCR). In addition, we quantified the expression of β3 integrin by immunohistochemistry (IHC) in a subset of 271 patients by H score. Outcome of interest was SLN biopsy metastasis within 90 days of melanoma diagnosis. Logistic regression analyses were used to develop models for the likelihood of SLN metastasis from molecular, clinical, and histologic variables.Resultsβ3 integrin expression quantified by IHC or RT‐qPCR was associated with SLN metastasis. β1, β5, β6, and β8 integrin expression was not associated with SLN metastasis. The incremental gain in performance of a predictive model which included β3 integrin expression as quantified by IHC in combination with established clinicopathologic variables (Breslow depth and patient age) was limited.Conclusionsβ3 integrin is the principal integrin subunit associated with sentinel lymph node biopsy (SLNb) metastasis in primary cutaneous melanoma. However, β3 integrin H score does not significantly improve models for the likelihood of SLN metastasis over Breslow depth and patient age.
Utilization and procedural adverse outcomes associated with Watchman device implantation
Khalil, Fouad , Arora, Shilpkumar , Killu, Ammar M. , Egbe, Alexander C. , Kapa, Suraj , Mulpuru, Siva K. , Mohamad, Alkhouli, Friedman, Paul A. , Holmes, David R. , Deshmukh, Abhishek , Mulpuru, Siva, Khalil, Fouad , Kapa, Suraj , Tripathi, Byomesh , DeSimone, Christopher V. , Noseworthy, Peter A. , Gersh, Bernard J.

Mayo Clinic

EP Europace | August 9, 2020 | Volume: 23 | Issue: 2 | Pages: 247-253

10.1093/europace/euaa219 | PMID 32929501 Get It

AbstractAims The Food and Drug Administration (FDA) approval of the Watchman device [percutaneous left atrial appendage occlusion (LAAO)] has resulted in the widespread use of this procedure in many centres across the USA. We sought to estimate the nationwide utilization and frequency of adverse outcomes associated with Watchman device implantation. The objective of this study was to evaluate the Watchman device implantation peri-procedural complications and comparison of the results with the previous studies.Methods and results The National Inpatient Sample (NIS) was queried for all hospitalizations with a primary diagnosis of atrial fibrillation or atrial flutter during the year 2016 with percutaneous LAAO during the same admission (ICD-10 code—02L73DK). The frequency of peri-procedural complications, including mortality, procedure-related stroke, major bleeding requiring blood transfusion, and pericardial effusion, was assessed. We compared the complication rates with the published randomized controlled trials and the European Watchman registry. An estimated 5175 LAAO procedures were performed in 2016. The majority of procedures was performed in males (59.1%), age ≥75 years (58.7%), and White (83.1%). The overall complication rate was 1.9%. The in-hospital mortality was 0.29%. Pericardial effusion requiring pericardiocentesis was the most frequent complication (0.68%). Bleeding requiring transfusion was noted in 0.1% of device implants. The rates of post-procedure stroke and systemic embolism were 0% and 0.29%, respectively.Conclusion Percutaneous LAAO with the Watchman device in the USA is associated with low in-hospital complications and a similar safety profile to a recently published EWOLUTION cohort. The complication rates were lower than those reported in the major randomized clinical trials (RCTs). We report the frequency of peri-procedural complications of the LAAO using the Watchman device from the NIS database. We also compare the frequency of peri-procedural complications with the previously published RCTs and EWOLUTION cohort. Our findings are in concordance with findings from EWOLUTION cohort and compare favourably with RCTs.
Big data in epilepsy: Clinical and research considerations. Report from the Epilepsy Big Data Task Force of the International League Against Epilepsy
Lhatoo, Samden , Bernasconi, Neda , Braun, Kees P. J. , Buchhalter, Jeffrey , Denaxas, Spiros , Galanopoulou, Aristea S. , Josephson, Colin B. , Kobow, Katja , Lowenstein, Daniel H. , Ryvlin, Philippe , Schulze‐Bonhage, Andreas , Sahoo, Satya S. , Thurman, David J. , Wiebe, Samuel , Lhatoo, Samden D , Galanopoulou, Aristea , Josephson, Colin , Kobow, Katja , Ryvlin, Philippe , Thom, Maria , Wiebe, Samuel , Schulze-Bonhage, Andreas , Blümcke, Ingmar , Worrell, Gregory A. , Zhang, Guo‐Qiang

Mayo Clinic

Epilepsia | August 8, 2020 | Volume: 61 | Issue: 9 | Pages: 1869-1883

10.1111/epi.16633 | PMID 32767763 Get It

AbstractEpilepsy is a heterogeneous condition with disparate etiologies and phenotypic and genotypic characteristics. Clinical and research aspects are accordingly varied, ranging from epidemiological to molecular, spanning clinical trials and outcomes, gene and drug discovery, imaging, electroencephalography, pathology, epilepsy surgery, digital technologies, and numerous others. Epilepsy data are collected in the terabytes and petabytes, pushing the limits of current capabilities. Modern computing firepower and advances in machine and deep learning, pioneered in other diseases, open up exciting possibilities for epilepsy too. However, without carefully designed approaches to acquiring, standardizing, curating, and making available such data, there is a risk of failure. Thus, careful construction of relevant ontologies, with intimate stakeholder inputs, provides the requisite scaffolding for more ambitious big data undertakings, such as an epilepsy data commons. In this review, we assess the clinical and research epilepsy landscapes in the big data arena, current challenges, and future directions, and make the case for a systematic approach to epilepsy big data.
Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies
Lee, Alice W. , Rosenzweig, Stacey, Wiensch, Ashley , Group, the Australian Ovarian Cancer Study, Ramus, Susan J. , Menon, Usha , Ziogas, Argyrios , Anton‐Culver, Hoda , Whittemore, Alice S. , Sieh, Weiva , Rothstein, Joseph H. , McGuire, Valerie, Wentzensen, Nicolas , Qin, Bo , Terry, Kathryn L. , Titus, Linda , Schildkraut, Joellen M. , Goode, Ellen L. , Jordan, Susan J. , Ness, Roberta B., Moysich, Kirsten B. , Thompson, Pamela J., Goodman, Marc T. , Carney, Michael E. , Chang‐Claude, Jenny , Rossing, Mary Anne, Khoja, Lilah , Alimujiang, Aliya , Phung, Minh Tung , Brieger, Katharine K. , Wu, Anna H. , Pike, Malcolm C. , Webb, Penelope M. , Pearce, Celeste Leigh , Ramus, Susan J , Webb, Penelope M , Menon, Usha , Anton-Culver, Hoda , Moysich, Kirsten , Sieh, Weiva , Ziogas, Argyrios , Qin, Bo , Khoja, Lilah , Goodman, Marc T , Group, the Australian Ovarian Cancer Study, Gentry‐Maharaj, Aleksandra , Bandera, Elisa V. , Cramer, Daniel W. , Berchuck, Andrew , Kjær, Susanne K. , Jensen, Allan , Modugno, Francesmary , Harris, Holly R. , Doherty, Jennifer A. , Risch, Harvey A. , Mukherjee, Bhramar , Pharoah, Paul D.P. , Phung, Minh Tung

Mayo Clinic

JNCI: Journal of the National Cancer Institute | August 4, 2020 | Volume: 113 | Issue: 3 | Pages: 301-308

10.1093/jnci/djaa099 | PMID 32766851 Get It

Abstract Background Parity is associated with decreased risk of invasive ovarian cancer; however, the relationship between incomplete pregnancies and invasive ovarian cancer risk is unclear. This relationship was examined using 15 case-control studies from the Ovarian Cancer Association Consortium (OCAC). Histotype-specific associations, which have not been examined previously with large sample sizes, were also evaluated. Methods A pooled analysis of 10 470 invasive epithelial ovarian cancer cases and 16 942 controls was conducted. Odds ratios (ORs) and 95% confidence intervals (CIs) for the association between incomplete pregnancies and invasive epithelial ovarian cancer were estimated using logistic regression. All models were conditioned on OCAC study, race and ethnicity, age, and education level and adjusted for number of complete pregnancies, oral contraceptive use, and history of breastfeeding. The same approach was used for histotype-specific analyses. Results Ever having an incomplete pregnancy was associated with a 16% reduction in ovarian cancer risk (OR = 0.84, 95% CI = 0.79 to 0.89). There was a trend of decreasing risk with increasing number of incomplete pregnancies (2-sided Ptrend < .001). An inverse association was observed for all major histotypes; it was strongest for clear cell ovarian cancer. Conclusions Incomplete pregnancies are associated with a reduced risk of invasive epithelial ovarian cancer. Pregnancy, including incomplete pregnancy, was associated with a greater reduction in risk of clear cell ovarian cancer, but the result was broadly consistent across histotypes. Future work should focus on understanding the mechanisms underlying this reduced risk.
Complete abdomen and pelvis segmentation using U‐net variant architecture
Weston, Alexander D. , Korfiatis, Panagiotis , Philbrick, Kenneth A. , Conte, Gian Marco , Kostandy, Petro, Sakinis, Thomas, Zeinoddini, Atefeh , Boonrod, Arunnit, Moynagh, Michael R., Takahashi, Naoki , Moynagh, Michael, Conte, Gian Marco , Takahashi, Naoki , Zeinoddini, Atefeh, Erickson, Bradley J.

Mayo Clinic

Medical Physics | August 2, 2020 | Volume: 47 | Issue: 11 | Pages: 5609-5618

10.1002/mp.14422 | PMID 32740931 Get It

PurposeOrgan segmentation of computed tomography (CT) imaging is essential for radiotherapy treatment planning. Treatment planning requires segmentation not only of the affected tissue, but nearby healthy organs‐at‐risk, which is laborious and time‐consuming. We present a fully automated segmentation method based on the three‐dimensional (3D) U‐Net convolutional neural network (CNN) capable of whole abdomen and pelvis segmentation into 33 unique organ and tissue structures, including tissues that may be overlooked by other automated segmentation approaches such as adipose tissue, skeletal muscle, and connective tissue and vessels. Whole abdomen segmentation is capable of quantifying exposure beyond a handful of organs‐at‐risk to all tissues within the abdomen.MethodsSixty‐six (66) CT examinations of 64 individuals were included in the training and validation sets and 18 CT examinations from 16 individuals were included in the test set. All pixels in each examination were segmented by image analysts (with physician correction) and assigned one of 33 labels. Segmentation was performed with a 3D U‐Net variant architecture which included residual blocks, and model performance was quantified on 18 test cases. Human interobserver variability (using semiautomated segmentation) was also reported on two scans, and manual interobserver variability of three individuals was reported on one scan. Model performance was also compared to several of the best models reported in the literature for multiple organ segmentation.ResultsThe accuracy of the 3D U‐Net model ranges from a Dice coefficient of 0.95 in the liver, 0.93 in the kidneys, 0.79 in the pancreas, 0.69 in the adrenals, and 0.51 in the renal arteries. Model accuracy is within 5% of human segmentation in eight of 19 organs and within 10% accuracy in 13 of 19 organs.ConclusionsThe CNN approaches the accuracy of human tracers and on certain complex organs displays more consistent prediction than human tracers. Fully automated deep learning‐based segmentation of CT abdomen has the potential to improve both the speed and accuracy of radiotherapy dose prediction for organs‐at‐risk.
8q24 Clear Cell Renal Cell Carcinoma Germline Variant is Associated with VHL Mutation Status and Clinical Aggressiveness
Eckel‐Passow, Jeanette E. , Yan, Huihuang , Kosel, Matthew, Serie, Daniel, Decker, Paul A. , Jenkins, Robert B. , Costello, Brian A. , Leibovich, Bradley C. , Parker, Alexander S. , Decker, Paul A. , Ho, Thai H.

Mayo Clinic

No container title available | July 27, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-48012/v1 Get It

Abstract Background: The four most commonly-mutated genes in clear cell renal cell carcinoma (ccRCC) tumors are BAP1, PBRM1, SETD2 and VHL. And, there are currently 14 known RCC germline variants that have been reproducibly shown to be associated with RCC risk. However, the association of germline genetics with tumor genetics and clinical aggressiveness are unknown.Methods: We analyzed 420 ccRCC patients from The Cancer Genome Atlas (TCGA). Molecular subtype was determined based on acquired mutations in BAP1, PBRM1, SETD2 and VHL. Aggressive subtype was defined clinically using Mayo SSIGN score and molecularly using the ccA/ccB gene expression subtype. Publically-available Hi-C data were used to link germline risk variants with candidate target genes. Results: The 8q24 variant rs35252396 was significantly associated with VHL mutation status (OR=1.6, p=0.0037) and SSIGN score (OR=1.9, p=0.00094), after adjusting for multiple comparisons. We observed that, while some germline variants have interactions with nearby genes, some variants demonstrate long-range interactions with target genes.Conclusions: These data further demonstrate the link between rs35252396, HIF pathway and ccRCC clinical aggressiveness, providing a more comprehensive picture of how germline genetics and tumor genetics interact with respect to tumor development and progression.
Microfluidic confinement enhances phenotype and function of hepatocyte spheroids
Choi, Jong Hoon , Loarca, Lorena, Hoyos‐Vega, José M. de , Dadgar, Neda , Loutherback, Kevin , Shah, Vijay H. , Revzin, Alexander , De Hoyos-Vega, Jose M, de Hoyos-Vega, Jose M , Stybayeva, Gulnaz

Mayo Clinic

American Journal of Physiology-Cell Physiology | July 22, 2020 | Volume: 319 | Issue: 3 | Pages: C552-C560

10.1152/ajpcell.00094.2020 | PMID 32697600 Get It

A number of cell culture approaches have been described for maintenance of primary hepatocytes. Forming hepatocytes into three-dimensional (3-D) spheroids is one well-accepted method for extending epithelial phenotype of these cells. Our laboratory has previously observed enhanced function of two-dimensional (2-D, monolayer) hepatocyte cultures in microfluidic devices due to increased production of several hepato-inductive growth factors, including hepatocyte growth factor (HGF). In the present study, we wanted to test a hypothesis that culturing hepatocyte spheroids (3-D) in microfluidic devices will also result in enhanced phenotype and function. To test this hypothesis, we fabricated devices with small and large volumes. Both types of devices included a microstructured floor containing arrays of pyramidal wells to promote assembly of hepatocytes into spheroids with individual diameters of ~100 µm. The hepatocyte spheroids were found to be more functional, as evidenced by higher level of albumin synthesis, bile acid production, and hepatic enzyme expression, in low-volume compared with large-volume devices. Importantly, high functionality of spheroid cultures correlated with elevated levels of HGF secretion. Although decay of hepatic function (albumin secretion) was observed over the course 3 wk, this behavior could be abrogated by inhibiting TGF-β1 signaling. With TGF-β1 inhibitor, microfluidic hepatocyte spheroid cultures maintained high and stable levels of albumin synthesis over the course of 4 wk. To further highlight utility of this culture platform for liver disease modeling, we carried out alcohol injury experiments in microfluidic devices and tested protective effects of interleukin-22: a potential therapy for alcoholic hepatitis.
Self‐injurious and suicidal behavior in young adults, teens, and children with epilepsy: A population‐based study
Wirrell, Elaine , Bieber, Ewa D. , Vanderwiel, Alexander, Kreps, Samantha , Weaver, Amy L. , Wirrell, Elaine C

Mayo Clinic

Epilepsia | July 22, 2020 | Volume: 61 | Issue: 9 | Pages: 1919-1930

10.1111/epi.16618 | PMID 32697369 Get It

AbstractObjectiveWhereas studies in adult epilepsy patients have shown higher rates of suicidal ideation and attempt, such studies in children are limited. Using the Rochester Epidemiology Project database, we compared the risk of self‐injurious behavior and suicidal ideation in a population‐based cohort of childhood epilepsy to controls.MethodsWe studied 339 cases with epilepsy and 678 age‐ and sex‐matched controls followed to a median age of 24.7 and 23.4 years, and identified 98 subjects with self‐injurious behavior or suicidal ideation (43 with epilepsy and 55 controls). All behaviors were categorized using the Columbia Suicide Severity Rating Scale.ResultsThose with epilepsy had a significantly higher rate of any self‐injurious behavior and suicidal ideation (hazard ratio [HR] = 1.56, 95% confidence interval [CI] = 1.04‐2.35) and tended to have an increased risk of suicidal ideation and attempt (HR = 1.48, 95% CI = 0.93‐2.37). The prevalence of preceding mood and substance abuse disorders was similarly high in both cases and controls with self‐injurious behavior or suicidal ideation; however, preceding attention‐deficit/hyperactivity disorder was more than twice as common in the epilepsy cases. Among cases with epilepsy, we did not identify any specific epilepsy‐related variable that was significantly correlated with risk of self‐injurious behavior or suicidal ideation.SignificanceChildren, teens, and young adults with a history of childhood epilepsy are at greater risk of self‐injurious behavior, highlighting the need for careful screening of mental health concerns as part of routine epilepsy care.